Authors Of Review Articles Research Articles

Pediatrics Standardized Concentration of Cardiovascular Intravenous Infusion Medications: A New Initiative in Saudi Arabia

International Journal of Pharmacology and Clinical Sciences,2020,9,2,70-75.DOI:10.5530/ijpcs.2020.9.13Published:May 2020Type:Review ArticleAuthors:Yousef Ahmed Alomi, Hani Alhamdan, and Faiz Abdullah Bahadig Author(s) affiliations:Yousef Ahmed Alomi*, BSc. Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE, Critical Care Clinical Pharmacists, TPN Clinical Pharmacist, Freelancer Business Planner, Content Editor and Data Analyst, Riyadh, Saudi Arabia. Hani Alhamdan, BSc.Pharm, MSc. Pharm, MBA Director, Pharmaceutical Care services Department at KAMC-Jeddah, Ministry of National Guard, Saudi Arabia. Faiz Abdullah Bah adig, R.Ph, Informatics Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical, City-WR-Jeddah, Ministry of National Guard, Saudi Arabia. Abstract:Objectives: To explore the pediatrics and neonates standardized concentration of cardiovascular intravenous infusion as new initiatives in the Kingdom of Saudi Arabia. Methods: It is a new initiative project drove by national standardized concentration of cardiovascular intravenous infusion services. The projects formulated from the international business model, pharmacy project guidelines and project management institution guidelines of a new project. The initiative project is written through project management professionals and consisted of several parts, including the initial phase, the planning phase, the execution phase, the monitoring and controlling phase. Results: Results indicates that the pediatrics and neonates standardized concentration of cardiovascular intravenous infusion services with a defined vision, mission and goals. The services had multiple benefits including clinical and economic on patients, the continuous of the project assured by risk management model description and the monitoring and controlling of the services as explored in the review. The transition to operation project though closing project stage confirmed in the analysis. Conclusion: The pediatrics and neonates standardized concentration of cardiovascular intravenous infusion services is a new initiative as part of the intravenous admixture program. The pediatrics and neonates standardized concentration of cardiovascular might diminution the workload of healthcare, pharmacy staff and avoid additional unnecessary economic burden on healthcare system; it is highly recommended to implement in the Kingdom of Saudi Arabia. Keywords:Cardiovascular, Concentration, Intravenous, Neonates, Pediatrics, Saudi Arabia, Services, StandardizedView:PDF (173.15 KB) PDFClick here to download the PDF file. Images Pediatrics Standardized Concentration of Cardiovascular Intravenous Infusion Medications: A New Initiative in Saudi Arabia

Therapeutic Interchange: New Initiative System in Saudi Arabia

International Journal of Pharmacology and Clinical Sciences,2020,9,1,10-13.DOI:10.5530/ijpcs.2020.9.3Published:February 2020Type:Review ArticleAuthors:Yousef Ahmed Alomi, and Faiz Abdullah Bahadig Author(s) affiliations:Yousef Ahmed Alomi*, BSc. Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE, Critical Care Clinical Pharmacists, TPN Clinical Pharmacist, Freelancer Business Planner, Content Editor and Data Analyst, Riyadh, Saudi Arabia. Faiz Abdullah. Bahadig, R.Ph, Informatics Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical, City-WR-Jeddah, Ministry of National Guard, Saudi Arabia. Abstract:Objective: To validate the therapeutic interchange system at healthcare institutions as new initiatives in the Kingdom of Saudi Arabia. Methods: It is a new initiative project drove by national therapeutic interchange system programs. The projects drove the therapeutic interchange system guidelines and the international business model, pharmacy project guidelines project management institution guidelines of a new project. The initiative project is written through project management professionals and contained of several parts, including the initial phase, the planning phase, the execution phase and the monitoring and controlling phase. Results: The therapeutic interchange services with a defined vision, mission and goals. The services had various aids, including clinical and economical, on patients and the healthcare system, as exemplified in the assessment. The continuation was of the project assured by the risk management model description. Besides, the monitoring and controlling of the services as declared. The transition to operation project, though closing the project stage, explored in the analysis. Conclusion: The therapeutic interchange system is a new initiative, part of the formulary management. There are various therapeutic interchange system classes of medications can be started though antibiotics, gastrointestinal medications and anti-psychiatric medications; it is highly recommended to implement in Saudi Arabia. Keywords:Drug Therapy, Initiative, Medications, Saudi Arabia, System, Therapeutic InterchangeView:PDF (161.95 KB) PDFClick here to download the PDF file. Images Table 1: Some therapeutic interchange studies

National Mass Gathering Pharmaceutical Care Program at Healthcare Institution in Saudi Arabia

International Journal of Pharmacology and Clinical Sciences,2020,9,1,1-4.DOI:10.5530/ijpcs.2020.9.1Published:February 2020Type:Review ArticleAuthors:Yousef Ahmed Alomi, Nouf Hameed AL-Muwallad, Nezar Adnan Yahya Khayat, Yasir Abdulraheem Bamagaus, Taha Mohamd Rafuden Bakhsh, Nojoud Adnan Khayat, Ahmad M. AlKharoby, and Wael H. Motair Author(s) affiliations:Yousef Ahmed Alomi*, Critical Care Clinical Pharmacists, TPN Clinical Pharmacist, Freelancer Business Planner, Content Edi tor and Data Analyst, Riyadh, Saudi Arabia. Nouf Hameed AL-Muwallad, Pharm D Staff Phar¬macist, Pharmaceutical Care Administration, Private hospital, Makkah, Saudi Arabia. Nezar Adnan Yahya Khayat, Bsc. Pharm Medication Safety Officer, Pharmaceutical Care Administration, Makkah Medical Affairs Region, Makkah, Saudi Arabia. Yasir Abdulraheem Bamagaus, Bsc. Pharm Regional General Manager, Pharmaceutical Care Administration, Makkah Medical Affairs Region, Makkah, Saudi Arabia. Taha Mohamd Rafuden Bakhsh, Bsc. Pharm Staff Pharmacist, Pharmaceutical Care Administration, Makkah Medical Affairs Region, Makkah, Saudi Arabia. Nojoud Adnan Khayat, Bsc. Pharm Staff Pharmacist, Pharmaceutical Care Administration, Makkah Medical Affairs Region, Makkah, Saudi Arabia. Ahmad M. AlKharoby, MD, Assistant General Manager for assistant medical affiars, Makkah Medical Affairs Region, Makkah, Saudi Arabia. Wael H. Motair, MD, General Manager, Makkah Medical Affairs Region, Makkah, Saudi Arabia. Abstract:Objective: To explore the pharmaceutical care services during mass gathering (MG) Hajj at the healthcare organizations in Saudi Arabia (SA). Methods: It is a descriptive analysis of a newly established program at the MOH in SA called MG pharmaceutical care program during Hajj and Umra Seasons, which was analyzed within the Pharmacy Strategic Plan 2012-2020 and update the plan with new Saudi vision 2030. Results: MG pharmaceutical care program is a new program established by the healthcare organizations in the last four years, which amongst to provide pharmaceutical care services in various fields. Conclusion: The mass gathering of pharmaceutical care services is a new initiative, part of the mass gathering medicine. The program should expand after the foundation stage with performance indication monitoring and follow up. Further assessment of the new project is required to validate the clinical and economic outcomes to research the high level of quality and professionalism in the future. Keywords:Healthcare, Institution, Mass Gathering, National, Pharmaceutical Care, Saudi ArabiaView:PDF (157.34 KB) PDFClick here to download the PDF file. Images National Mass Gathering Pharmaceutical Care Program at Healthcare Institution in Saudi Arabia

Adult Standardized Concentration of Antibiotics Intravenous Infusion: New Initiative in Saudi Arabia

International Journal of Pharmacology and Clinical Sciences,2020,9,1,20-26.DOI:10.5530/ijpcs.2020.9.5Published:February 2020Type:Review ArticleAuthors:Yousef Ahmed Alomi, Hani Alhamdan, and Faiz Abdullah Bahadig Author(s) affiliations:Yousef Ahmed Alomi*, BSc. Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE, Critical Care Clinical Pharmacists, TPN Clinical Pharmacist, Freelancer Business Planner, Content Editor and Data Analyst, Riyadh, Saudi Arabia. Ghaidaa Ali Alhazmi, Pharm D Distributive Pharmacist, Riyadh, Saudi Arabia. Faiz Abdullah. Bahadig, R.Ph, Informatics Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical, City-WR-Jeddah, Ministry of National Guard, Saudi Arabia. Hani Alhamdan, BSc.Pharm, MSc. Pharm, MBA, Director, Pharmaceutical Care services Department at KAMC-Jeddah, Ministry of National Guard, Saudi Arabia. Abstract:Objectives: To demonstrate the adult standardized concentration of Antibiotics intravenous infusion as new initiatives in the Kingdom of Saudi Arabia. Methods: It is a new initiative project drove by national standardized concentration of Antibiotics services. The projects formulated from the international business model, pharmacy project guidelines and project management institution guidelines of a new project. The initiative project is written through project management professionals and contained of several parts, including the initial phase, the planning phase, the execution phase, the monitoring and controlling phase. Results: The adult standardized concentration of Antibiotics intravenous infusion services with a defined vision, mission and goals. The services had various benefits including clinical and economic on patients as exemplified in the review. The continuous of the project assured by risk management model description. In addition, the monitoring and controlling of the services as declared. The transition to operation project though closing project stage was explored in the analysis. Conclusion: The adult standardized concentration of Antibiotics intravenous infusion services is a new initiative part of the intravenous admixture program. The standardized concentration of Antibiotics will lessening drug-related problems and improve patient safety at hospital practice; it is highly recommended to implement in the Kingdom of Saudi Arabia. Keywords:Adult, Antibiotics, Concentration, Intravenous, Saudi Arabia, Services, StandardizedView:PDF (227.19 KB) PDFClick here to download the PDF file. Images Adult Standardized Concentration of Antibiotics Intravenous Infusion: New Initiative in Saudi Arabia

Cross-trial comparisons in reviews: proceed with caution.

To gauge the relative efficacy of treatments, authors of review articles and commentary might attempt to compare results across clinical trials, but failure to recognize inherent differences across studies or apply proper statistical principles could yield flawed conclusions. Several approaches can mitigate the risks in these cross-trial comparisons.

National Medication Utilization Evaluation Program in Saudi Arabia

International Journal of Pharmacology and Clinical Sciences,2019,8,3,156-157.DOI:10.5530/ijpcs.2019.8.25Published:September 2019Type:Review ArticleAuthors:Yousef Ahmed Alomi, and Abeer Hussin Almasoudi Author(s) affiliations:Yousef Ahmed Alomi*, The Former General Manager of General Administration of Pharmaceutical Care and Head, National Clinical pharmacy, and Pharmacy Practice and Pharmacy R & D Administration, MOH, Riyadh, Saudi Arabia. Abeer Hussin Almasoudi, Director, Administration of Research and Studies, Ministry of Health, Tabuk, Saudi Arabia. Abstract:The national Medication Utilization Evaluation Program at the Ministry of health in Saudi Arabia with complimentary of physician order techniques is new system founded in the Kingdom of Saudi Arabia. The programming part of pharmacy strategic planning and national pharmacy practice at health care services at the Ministry of health. The Medication Utilization Evaluation program started with evidence-based medicine guidelines. The new project of Medication Utilization Evaluation physician order was one the outcome of the program. The program steps development through central committee by Pharmacy department at the most prominent hospital crossover regions in Saudi Arabia. The project is complementary of pharmaceutical concept and alerting system of misuse of medications and subsequences medication-related problems and avoids the unnecessary economic burden on the healthcare system. The new national Medication Utilization Evaluation project is new in Saudi Arabia, Gulf, and Middle East counties. Keywords:Evaluation, Medication, Ministry of Health, Ministry of health in Saudi Arabia, Saudi Arabia, UtilizationView:PDF (1.57 MB) PDFClick here to download the PDF file. Images National Medication Utilization Evaluation Program in Saudi Arabia

Neonates and Pediatrics Electrolyte Replacement Therapy Order: New Initiative and Implementation System in Saudi Arabia

International Journal of Pharmacology and Clinical Sciences,2019,8,4,211-212.DOI:10.5530/ijpcs.2019.8.47Published:December 2019Type:Review ArticleAuthors:Yousef Ahmed Alomi, Fatimah Al-Doughan, Yasir Ahmed Ibrahim, Hussam Saad Almalki, Nouf Alaza, and Malika Alshamari Author(s) affiliations:Yousef Ahmed Alomi*, The Former General Manager of General Administration of Pharmaceutical Care, The Former Head, National Clinical pharmacy and pharmacy practice, The Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Fatimah Al-Doughan, College of Pharmacy, Pharmacy Practice Department, King Faisal University Alahssa, SAUDI ARABIA. Yasir Ahmed Ibrahim, Head of Pharmacy Practice Department, Pharmacy Practice Department, College of Clinical Pharmacy, King Faisal University, Alahssa, SAUDI ARABIA. Hussam Saad Almalki, Supervisor of IV Admixture Services, Aleman Hospital, Ministry of Health, Riyadh, Riyadh, SAUDI ARABIA. Nouf Alaza, Director of Medication Safety Officer, Pharmacy Services, Alyammama Hospital Ministry of Health, Riyadh, SAUDI ARABIA. Malika Alshamari, Head, Pharmacy services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA. Abstract:The national medications safety program founded in 2013 at the Ministry of Health hospitals and primary care centers in the Kingdom of Saudi Arabia. The program focused on adults, pediatrics and neonatal populations. The program was part of the pharmacy strategic plan. The electrolyte replacement therapy preparation and administration for neonates and pediatrics published and distributed as required of the medication safety program. The new initiatives as complementary project was a standardized concentration of electrolyte replacement therapy for neonates and pediatrics implemented at specific hospitals of the Ministry of health. The new project as regular physician’s order form and coveted to computerized physician order entry. The new project prevents neonates and pediatrics medication errors of electrolyte replacement therapy. The project is a new initiative at Ministry of Health hospitals in the Kingdom of Saudi, Gulf and Middle East countries. Keywords:Electrolyte, Ministry of Health, Neonates, Pediatrics, Saudi Arabia, Standardized ConcentrationView:PDF (644.37 KB) PDFClick here to download the PDF file. Images Neonates and Pediatrics Electrolyte Replacement Therapy Order: New Initiative and Implementation System in Saudi Arabia

National Pharmacists On-the-Job Training program at the Ministry of Health in Saudi Arabia

International Journal of Pharmacology and Clinical Sciences,2019,8,2,94-98.DOI:10.5530/ijpcs.2019.8.16Published:June 2019Type:Review Article Authors:Yousef Ahmed Alomi, Saeed Jamaan Alghamdi, and Radi Abdullah Alatty2 Author(s) affiliations:Yousef Ahmed Alomi1,* , Saeed Jamaan Alghamdi2, Radi Abdullah Alatty2 1The Former General Manager of General Administration of Pharmaceutical Care, The Former Head, National Clinical pharmacy and pharmacy practice, The Former Head, Pharmacy R and D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. 2General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Abstract:Objective: To explore the pharmacists on the job training at the Ministry of Health hospitals in the Kingdom of Saudi Arabia. Methods: It is a descriptive analysis of pharmacists on the job training at the Ministry of Health hospitals. It was within the pharmacy strategic plan 2012-2020. The study used the changed pharmacy business model system and Project Management Procedure. Results: The pharmacists on job training system reputable with a defined vision, mission and goals. The system had some properties including human or economic and other defined in the review. The continuation of the system guaranteed by risk management model explanation. Also, the monitoring and controlling of the system as exemplified. The convention to operation project though closing project stage established in the examination. Conclusion: The pharmacists on job training system well-known within the healthcare system and pharmacy regulations. The pharmacists on the job training system are regularly refining consequently at all Ministry of Health hospitals in the Kingdom of Saudi Arabia. Keywords:Job, Ministry of Health, Pharmacists, Saudi Arabia, TrainingView:PDF (306.53 KB) PDFClick here to download the PDF file. Images Pharmacist on job training program modules and duration of training

Schizophrenia Treatment Physician Order: New Initiatives at the Mental Hospital of Ministry of Health in Saudi Arabia

International Journal of Pharmacology and Clinical Sciences,2018,7,4,2-3.DOI:10.5530/ijpcs.2018.7.2Published:November 2018Type:Review ArticleAuthors:Yousef Ahmed Alomi, Nora Alsolami, Nada Alqahtani, Dalal Alqahtani, and Saeed Alqahtani Author(s) affiliations:Yousef Ahmed Alomi1,* , Nora Alsolami2, Nada Alqahtani3, Dalal Alqahtani4, Saeed Alqahtani5 1The Past General Manager of General Administration of Pharmaceutical Care Head, National Clinical Pharmacy and Pharmacy Practice Programs, Head, Pharmacy R and D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. 2Head, Pharmaceutical Care Services, Al-Amel Medical Complex, Ministry of Health, Riyadh, Riyadh, SAUDI ARABIA. 3Head, Drug Information Services, Al-Amel Medical Complex, Ministry of Health, Riyadh, SAUDI ARABIA. 4Clinical Pharmacy Staff, Al-Amel Medical Complex, Ministry of Health, Riyadh, SAUDI ARABIA. Abstract:The general administration of pharmaceutical care at the Ministry of Health in Saudi Arabia has released several pharmacy practice programs. The national pharmacy psychiatric program was one among them. This program has been established for the psychiatric management with an emphasis on schizophrenia. The guidelines inthis program have been implemented in the form of a physician order form. This form consists of the best therapeutic choice for the conventional type of schizophrenia, or schizophrenia with comorbid disease. The schizophrenia guidelines have been approved by the medical staff and have been implemented at the hospital. This type of management of schizophrenia will prevent drug-related problems and improve clinical outcome of the patients. It is the first new initiative project at the Ministry of Health and in the Middle Eastern countries. Keywords:Ministry of Health, Physician Oder, Saudi Arabia, Schizophrenia treatmentView:PDF (256.38 KB) PDFClick here to download the PDF file. Images International Journal of Pharmacy and Health Sciences

Antipsychotic medication therapy during the holy month of Ramadan: a literature review

Pharmacology, Toxicology and Biomedical Reports,2019,5,2,79-83.DOI:10.5530/PTB.2019.5.14Published:July 2019Type:Review ArticleAuthors:Yousef Ahmed Alomi, Jude Alhowaidi, Raneem Alzeer, Ali Alhowaidi, and Nora Alhowaidi Author(s) affiliations:Yousef Ahmed Alomi*, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Jude Alhowaidi, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Raneem Alzeer, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Ali Alhowaidi, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Nora Alhowaidi, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Abstract:Objectives: To review the antipsychotic medication therapy during the holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease, and medication based on therapeutic class. The search on antipsychotic and anti-epileptic medication list and switch from regular days to Ramadan days included comparative safety, efficacy and cost of type of medication for each disease and national or international evidencebased guidelines including those switching short half-life to long half-life drugs. All nonoral dosage form of medication will be excluded in this study. All medications should be documented in the Ministry of Health drug formulary. Results: A total of 710 studies were shortlisted after an extensive search with specific terms. Of those, 104 studies were duplicate studies; therefore only 606 studies were included for further evaluation. The evaluation revealed that 27 studies discussed about the antipsychotic medications and Ramadan. Of these, only five were appropriate for further revision. According to our results, most of the studies were observational studies and a few have conducted experimental design studies. Three studies have a shared or similar study design (i.e., reports). Among all the reports analyzed in this study, most of them used study design. On the contrary, three studies mentioned the utilization of a descriptive approach; however, none of the studies mentioned the exact type of descriptive analysis conducted. One study was a clinical review and another study mentioned the applicability of a randomized controlled trial. Based on this, the authors suggested switching the antipsychotic and anti-epileptic medication from regular days to Ramadan days. Conclusion: There are no randomized clinical trials in the literature to validate the switching of medication from regular to Ramadan days. A list of antipsychotic medications that can be used to switch during Ramadan is highly warranted. Further studies to validate the medication used to treat psychiatric conditions during the holy month of Ramadan is recommended. Keywords:Antipsychotic, Medication, Ramadan, Review, TherapyView:PDF (180.89 KB) PDF PDF Images The selected studies conducted during the holy month of Ramadan.

Drug therapy for chronic diseases during the holy month of Ramadan: a literature review

Pharmacology, Toxicology and Biomedical Reports,2019,5,2,75-78.DOI:10.5530/PTB.2019.5.13Published:July 2019Type:Review ArticleAuthors:Yousef Ahmed Alomi, Ban Abdullah Aldosary, Nasser Faleh Aldawas, and Rana Mohammed Alslim Author(s) affiliations:Yousef Ahmed Alomi*, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Ban Abdullah Aldosary, Pharmaceutical Care Department, Al-Amel Mental City, Ministry of Health, Riyadh, SAUDI ARABIA. Nasser Faleh Aldawas, Consultant Gastroenterologist, Ministry of Health, Riyadh, SAUDI ARABIA. Rana Mohammed Alslim, Ministry of Health, Riyadh, SAUDI ARABIA. Abstract:Objectives: In this study, we aimed to review the drug therapy for chronic diseases during the holy month of Ramadan. Methods: In this study, we conducted an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease, and medication based on therapeutic class. Medication list related to the gastrointestinal tract diseases, asthma and rheumatoid arthritis and the switch from regular days to Ramadan days revealed comparative safety, efficacy studies, cost of type of medication for each disease studies and national or international evidence based guidelines of switching short halflife to long half-life. All parenteral dosage form of medication were excluded from the analysis. All medications should be listed in the MOH drug formulary. Results: A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 studies were included for further evaluation. The evaluation revealed that 27 studies investigated medications related to the gastrointestinal diseases and Ramadan and 15 studies were about medicines for asthma and rheumatoid arthritis and Ramadan. Of those 42 studies of Ramadan and chronic diseases, only 5 studies were found to be appropriate for further evaluation. The suggested draft of list of medications of chronic diseases from regular days to the Ramadan days is explored in the review. Conclusion: The guidelines medications of chronic disease (Asthma, RA, GIT disease) intake during the holy month of Ramadan is not found. The studies of drug schedules in Ramadan does not exist. The investigations about medications therapy of chronic disease are highly recommended in Muslim countries. Keywords:Chronic diseases, Drug, Literature, Ramadan, Review, TherapyView:PDF (185.67 KB) PDF PDF Images The Chronic Diseases (GIT, RA, Asthma) studies conducted during the holy month of Ramadan.

Intake of antibiotics and fasting during the holy month of Ramadan: A Literature Review

Pharmacology, Toxicology and Biomedical Reports,2019,5,2,65-68.DOI:10.5530/PTB.2019.5.11Published:July 2019Type:Review ArticleAuthors:Yousef Ahmed Alomi, Mohammed Abdulaziz Altuwaijri, Mohsen Huraybie Alshammari, and Nouf Hameed Al-Muallad Author(s) affiliations:Yousef Ahmed Alomi*, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Mohammed Abdulaziz Altuwaijri, ENT Consultant, King Saud Medical City, Riyadh, SAUDI ARABIA. Mohsen Huraybie Alshammari, Hail Maternaty and Childern Hospital, Ministry of Health, Hail, SAUDI ARABIA. Nouf Hameed Al-Muallad, Ibn Sina College Hospital, Jeddah, SAUDI ARABIA. Abstract:Objectives: To review the intake of antibiotics and fasting during the holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases following the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language with human study only for update May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease and medication based on therapeutic class. The list of antibiotic medication and switch from regular days to Ramadan days based on literature search revealed comparative safety studies, efficacy studies and cost of type of medication for each disease studies and national or international evidence-based guidelines of switching short half-life to long halflife. All parenteral dosage form of medication were excluded from study. All medications should be listed in the Ministry of Health drug formulary. Results: A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 were considered for further evaluation. After evaluation, we obtained 30 studies which discussed about the antibiotics and Ramadan. Of these 30 studies, only 2 studies were found to be appropriate for further revision. Among the two, one study was an observational study regarding the pattern of prescribing antibiotics during the holy month of Ramadan. The second study was about the systemic review on the safety of fasting and several infectious diseases. The suggested draft of list of antibiotic switch from regular days to the holy Ramadan days was explored in this review. Conclusion: The investigations about antibiotics intake during fasting not found. The studies of antibiotic during the holy month of Ramadan is required during legal registrations at all Muslim countries. Antibiotics switch therapy during fasting is highly recommended at all Muslim patients in the world. Keywords:Antibiotics, Fasting, Literature, Ramadan, ReviewView:PDF (190.51 KB) PDF PDF Images Table 1: The antibiotic studies conducted during the holy month of Ramadan.

National Adverse Drug Reaction Reporting System at the Ministry of Health, Saudi Arabia

Pharmacology, Toxicology and Biomedical Reports,2018,4,3,21-23.DOI:10.5530/PTB.2018.4.8Published:September 2018Type:Review ArticleAuthors:Yousef Ahmed Alomi, Saeed Jamaan Alghamdi, and Radi Abdullah Alattyh Author(s) affiliations:Yousef Ahmed Alomi1, Saeed Jamaan Alghamdi2, Radi Abdullah Alattyh3 1The Former General Manager of General Administration of Pharmaceutical Care, The Former Head, National Clinical pharmacy and pharmacy practice, The Former Head, Pharmacy R and D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. 2General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. 3General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Abstract:Objective: To illustrate the adverse drug reaction during the pharmacy strategic plan at the Ministry of Health of Health institutions in the Kingdom of Saudi Arabia. Method: It is description analysis of adverse drug reaction system at the Ministry of Health of Health institutions. It was analysis within the Pharmacy strategic plan 2012-2020. The modified pharmacy business model system and Project Management Procedure used in the report. Results: The adverse drug reaction established with a defined vision, mission and goals. The system human or economic and other resources described in the review. The risk management was discussed to assure the continuation of the system. Besides, the monitoring and controlling of the system as illustrated. The closing stage with convention to operation project demonstrated in the Analysis. Conclusion: The Adverse drug reaction system implemented and it is considered as part of the healthcare system and pharmacy regulations. The documentation of ADR is updating improving accordingly at all Ministry of Health institutions in the Kingdom of Saudi Arabia Keywords:Adverse drug reaction, Ministry of Health, Pharmaceutical Care, Saudi Arabia, SystemView:PDF (946.08 KB) PDF PDF Images National Adverse Drug Reaction Reporting System at the Ministry of Health, Saudi Arabia

National Corporate Pharmacy and Therapeutic Committee at the Ministry of Health, Saudi Arabia

Pharmacology, Toxicology and Biomedical Reports,2018,4,3,24-27.DOI:10.5530/PTB.2018.4.9Published:September 2018Type:Review ArticleAuthors:Yousef Ahmed Alomi, Saeed Jamaan Alghamdi, and Radi Abdullah Alattyh Author(s) affiliations:Yousef Ahmed Alomi1, Saeed Jamaan Alghamdi2, Radi Abdullah Alattyh3 1The Former General Manager of General Administration of Pharmaceutical Care, The Former Head, National Clinical pharmacy and pharmacy practice, The Former Head, Pharmacy R and D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. 2General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. 3General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Abstract:Objective: To review the Ministry of Health Corporate MOH Pharmacy and Therapeutic committee system at the Ministry of Health foundations in the Kingdom of Saudi Arabia. Method: It is a retrospective analysis of Ministry of Health Corporate MOH Pharmacy and Therapeutic committee system at Ministry of hospitals institutions. Its analysis illustrated within the Pharmacy strategic plan 2012-2020. The analysis process used. The modified pharmacy business model system and Project Management Procedure. Results: Ministry of Heath drug Corporate MOH Pharmacy and Therapeutic committee established with clear vision, mission and goals. The committee had human or economic and other resources described in the review. To assure the continuity of the system; the risk management was used and described. Besides, the monitoring and controlling of the system were demonstrated. The closing stage with convention to operation project shown in the Analysis. Conclusion: The Ministry of Health Corporate MOH Pharmacy and Therapeutic committee system founded though Pharmacy strategies and regulations. The Ministry of Health Corporate MOH Pharmacy and Therapeutic committee has regular development accordingly at all Ministry of Health hospitals and primary healthcare centers in the Kingdom of Saudi Arabia. Keywords:Ministry of Health, Pharmacy and Therapeutic Committee, Saudi ArabiaView:PDF (242.23 KB) PDF PDF Images National Corporate Pharmacy and Therapeutic Committee at the Ministry of Health, Saudi Arabia

On-the-Job Training of Pharmacy Technicians at the Ministry of Health Hospitals in Saudi Arabia

Pharmacology, Toxicology and Biomedical Reports,2018,4,3,34-36.DOI:10.5530/PTB.2018.4.12Published:September 2018Type:Review ArticleAuthors:Yousef Ahmed Alomi, Saeed Jamaan Alghamdi, and Radi Abdullah Alattyh Author(s) affiliations:Yousef Ahmed Alomi1, Saeed Jamaan Alghamdi2, Radi Abdullah Alattyh3, 1The Former General Manager of General Administration of Pharmaceutical Care, The Former Head, National Clinical pharmacy and pharmacy practice, The Former Head, Pharmacy R and D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. 2General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. 3General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Abstract:Objective: To demonstrate the pharmacy technicians on the job training at the Ministry of Health of Health hospitals in the Kingdom of Saudi Arabia. Method: It is a retrospective analysis of pharmacy technicians on job training project at the Ministry of Health of Health hospitals. It was within The Pharmacy strategic plan 2012-2020. The study used the modified pharmacy business model system and Project Management Procedure. Results: The pharmacy technicians on job training system established with a defined vision, mission and goals. The system had several resources including human or economic and other described in the review. The continuation of the system assured by risk management model description. Also, the monitoring and controlling of the system as illustrated. The convention to operation project though closing project stage demonstrated in the Analysis. Conclusion: The pharmacy technicians on job training system established within the healthcare system and pharmacy regulations. The pharmacy technicians on the job training system are regularly improving accordingly at all Ministry of Health hospitals in the Kingdom of Saudi Arabia. Keywords:Job, Ministry of Health, Pharmacy Technicians, Saudi Arabia, TrainingView:PDF (513.08 KB) PDF PDF Images On-the-Job Training of Pharmacy Technicians at the Ministry of Health Hospitals in Saudi Arabia

Celecoxib in Cancer Therapy and Prevention - Review.

It is generally accepted that inflammatory cells found in the tumor microenvironment are involved in the neoplastic process, promoting cell proliferation, survival, and migration. Therefore, administering anti-inflammatory medication in cancer therapy seems to be justified. A potential pathway associated with the aforementioned issue is cyclooxygenase-2 inhibition, particularly as the overexpression of this enzyme has been proven to occur in cancer tissues and is also associated with a poor prognosis in several types of human malignancies. Celecoxib, a COX-2 selective inhibitor, has been utilized for over 20 years, particularly as an anti-inflammatory, analgesic and antipyretic medication. However, to date, its antineoplastic properties have not been sufficiently investigated. In recent years, the number of research studies on the antineoplastic effects of celecoxib has increased considerably. The vast majority of publications refers to preclinical studies attempting to elucidate its mechanisms of action. Clinical trials concerning celecoxib have focused primarily on the treatment of cancers of the colon, breast, lung, prostate, stomach, head and neck, as well as premalignant lesions such as familial adenoma polyposis. In this review article authors attempt to summarise the latest research which has elucidated celecoxib use in the treatment and prevention of cancer. Both preclinical and clinical studies have demonstrated promising results of the role of celecoxib in the treatment and prevention of cancer - the best outcome was observed in colon, breast, prostate and head and neck cancers. However, more clinical trials providing real evidence-based clinical advances of celecoxib use are needed.

Indian seaweed resources: their availability and importance

The plant species which were found along the sea – shore was called as “seaweed”. They were reported all along the Indian coastal state waters in variable amount. Among all these Indian coastal states Tamil nadu and Gujarat states contributes more seaweed resource. Seaweed were mainly found along the coastal waters of the ocean. According to colouration and pigmentation in plants they were classified in three categories; i.e. Red, Brown and Green seaweed. The various reports were reported that seaweed are utilized for many different purposes all along the world. They were mainly utilized for food, medicine, fertilizers etc. in this review article authors were discussed about the availability of seaweed resources along Indian waters and the mineral and proximate composition of commercially important seaweed species, which represents seaweed is one of the most important resource in future and so in future this scenario will ultimately causes the utilization and demand of seaweed was going on increasing, not only along Asian countries but also from all over the world. The Indian waters consideration represents, there was very less importance was given to seaweed as that of other oceanic resource, but in future India also going to give importance to seaweed mainly because over-fishing/ over-harvesting of other oceanic resources like fishes, shell fishes, mammals etc. from Indian oceanic waters. so all these thing together concluded that in future seaweed will became as one of the best alternative option for human beings.

Ayurveda Understanding of Mastitis in Diary Animals

Journal of Ayurveda Medical Sciences,2018,3,2,351-355.DOI:10.5530/jams.2018.3.15Published:October 2018Type:Review ArticleAuthors:Kumar Seethakempanahalli Kempanna, Balakrishna Nair Mannoor Narayanan, Natesan Punniamurthy, and Girish Kumar Venkateshappa Author(s) affiliations:Kumar Seethakempanahalli Kempanna, Balakrishna Nair Mannoor Narayanan, Natesan Punniamurthy, Girish Kumar Venkateshappa University of TransDisciplinary Health Sciences and Technology (TDU), Formerly FRLHT, #74/2, Jarakbande kaval, Attur post, via Yelahanka, Bengaluru 560064, India. Abstract:The evidence from archeological sciences states that many countries were having various methods and practices for management of animal diseases. Veterinary science in India has a documented history of around 5000 years. There exists codified veterinary knowledge in the form of medical texts, manuscripts on various aspects of veterinary care such as health management of cattle, horses, birds, and elephants. The veterinary and animal husbandry practices were present and grown in the Vedic, Puranic and extending beyond Epic periods. This knowledge is available in the form of manuscripts called Veterinary Ayurveda, viz Mrugayurveda (Ayurveda for Animals), Pashupakshishastra (Ayurveda for birds), Hasthyayurveda (Ayurveda for elephants), Ashwayurveda (Ayurveda for horses) etc. Understanding the etiopathogenesis and management of animal diseases through Ayurveda is need of the day. Mastitis is the economically devastating diseases of dairy animals. The loss due to one such disease annually goes up to 7500 crores INR. The saints of Ayurveda have explained in detail about mastitis as Sthanavidhradi. The management and treatment modalities have clearly mentioned in the classics of Ayurveda. In this article, an effort has been taken to explain ethno and Ayurvedic understanding of the most economic devastating disease mastitis. It is also tried to establish the link between Ayurveda and Veterinary Ayurveda. This traditional system of India called Mrugayurveda (Ayurveda for Animals) or Veterinary Ayurveda is robust and time tested. It has been in practice since age old. This robust system of medicine can address the current challenges of mainstream medicine. Many herbs and formulation from Ethno knowledge and Ayurveda were in practice in ancient India. So it is important to validate and reintroduce these time tested formulations and herbs for animal health. Keywords:Ethnoveterinary, Mastitis, Sthanavidhradi, Veterinary AyurvedaView:PDF (2.57 MB)

GUL-E- SURKH (Rosa damascena Mill.) AND ITS THERAPEUTIC USES DESCRIBED IN UNANI LITERATURE

Gul-e-Surkh (Rose flower) is the Persian name for the Rosa damascena Mill. In Unani system of medicine Rose flower is used for medicinal purposes. Ibn Sina considers Gul-e- Surkh as one of the best drug for liver. Rose flower in various doses form and/or in combination with many other drugs are indicated in various disease. It is commonly being used as general tonic for Lungs, Stomach, Intestine, Liver, Rectum, Kidney, Heart, and Uterus. Fresh flowers are purgative and dried one is astringent in properties. In this review article authors try to encompass the therapeutic indication of Rosa damascena Mill described in Unani literature.

Non-Anesthetic Effects of Ketamine: A Review Article Authors

Ketamine is considered a dissociative anesthetic medication, and it is a commonly administered by a parenteral route. It works mainly by blocking the N-methyl-D-aspartate (NMDA) receptor. It inhibits the voltage-gated Na_ and K_ channels and serotonin and dopamine re-uptake; also, it affects specific receptors, such as α-amino-3-hydroxy- 5-methyl-4-isoxazolepropionic acid (AMPA), kainite and amino butyric acid A receptors. Ketamine appears to have particular mechanisms that are potentially involved during analgesic induction, including enhancing of descending inhibition and anti-inflammatory effects. More recently, it has been shown that ketamine has potential in clinical practice for the management of chronic pain, cognitive function, depression, acute brain injury and disorders of the immune system.